Logical Analysis Report

Key Focus

  • People with the chronic condition are at heightened risk of cardiovascular disease, Type 2 diabetes, 13 types of cancer, osteoarthritis, asthma and other health problems. ...
  • Her job with the Los Angeles Unified School District comes with health insurance that covers the pricey drugs and charges her a copay of $30 a month for her Mounjaro prescription. ...
  • In some parts of the country, Black patients with diabetes are only half as likely as white patients to get GLP-1 drugs, according to research by Dr. ...


More about Logical Analysis, please click here

High Level Topics

  • HEALTH
  • DIABETES
  • LOSS
  • High Level Abstractions

  • HEALTH
  • ( HEALTH )  top
  • ( HEALTH, DIABETES )  top
  • ( HEALTH, DIABETES, WHITE )  top
  • ( HEALTH, DIABETES, RISK )  top
  • ( HEALTH, DIABETES, OSTEOARTHRITIS )  top
  • ( HEALTH, DIABETES, MOUNJARO )  top
  • ( HEALTH, DIABETES, LOS_ANGELES_UNIFIED_SCHOOL_DISTRICT )  top
  • ( HEALTH, DIABETES, INSURANCE )  top
  • ( HEALTH, DIABETES, GLP-1 )  top
  • ( HEALTH, UNIVERSITY )  top
  • ( HEALTH, UNIVERSITY, WHITE )  top
  • ( HEALTH, UNIVERSITY, SERVICES )  top
  • ( HEALTH, UNIVERSITY, RESEARCHER )  top
  • ( HEALTH, UNIVERSITY, PHARMACEUTICAL )  top
  • ( HEALTH, UNIVERSITY, PENNSYLVANIA )  top
  • ( HEALTH, UNIVERSITY, JIGCHUAN_GUO )  top
  • ( HEALTH, UNIVERSITY, INCREASED )  top
  • ( HEALTH, INSURANCE )  top
  • ( HEALTH, INSURANCE, PRESCRIBED )  top
  • ( HEALTH, INSURANCE, MOUNJARO )  top
  • ( HEALTH, INSURANCE, LOS_ANGELES_UNIFIED_SCHOOL_DISTRICT )  top
  • ( HEALTH, INSURANCE, COPAY )  top
  • ( HEALTH, HOUSEHOLD )  top
  • ( HEALTH, DISEASE )  top
  • ( HEALTH, DISEASE, RISK )  top
  • ( HEALTH, DISEASE, OSTEOARTHRITIS )  top
  • ( HEALTH, DISEASE, DIABETES )  top
  • ( HEALTH, DISEASE, CHRONIC )  top
  • ( HEALTH, WHITE )  top
  • ( HEALTH, SOUTH_FLORIDA )  top
  • ( HEALTH, SERVICES )  top
  • DIABETES
  • ( DIABETES )  top
  • ( DIABETES, WHITE )  top
  • ( DIABETES, WHITE, GLP-1 )  top
  • ( DIABETES, WHITE, EBERLY )  top
  • ( DIABETES, WHITE, COUNTRY )  top
  • ( DIABETES, WHITE, COLLEAGUES )  top
  • ( DIABETES, RISK )  top
  • ( DIABETES, RISK, OSTEOARTHRITIS )  top
  • ( DIABETES, RISK, FOOD )  top
  • ( DIABETES, RISK, DRUG_ADMINISTRATION )  top
  • ( DIABETES, RISK, DISEASE )  top
  • ( DIABETES, RISK, CHRONIC )  top
  • ( DIABETES, RISK, ATTACKS )  top
  • ( DIABETES, OZEMPIC )  top
  • ( DIABETES, MOUNJARO )  top
  • ( DIABETES, GLP-1 )  top
  • ( DIABETES, GLP-1, SO-CALLED )  top
  • ( DIABETES, GLP-1, RECEPTOR )  top
  • ( DIABETES, GLP-1, DAY )  top
  • ( DIABETES, GLP-1, COUNTRY )  top
  • ( DIABETES, GLP-1, AGONIST )  top
  • ( DIABETES, UNIVERSAL_STUDIOS )  top
  • ( DIABETES, SO-CALLED )  top
  • LOSS
  • ( LOSS )  top
  • ( LOSS, DRUG )  top
  • ( LOSS, DRUG, FDA )  top
  • ( LOSS, DRUG, FDA, WEGOVY )  top
  • ( LOSS, DRUG, FDA, DIABETES )  top
  • ( LOSS, DRUG, WEGOVY )  top
  • ( LOSS, DRUG, TAG )  top
  • ( LOSS, DRUG, STOP )  top
  • ( LOSS, DRUG, DIABETES )  top
  • ( LOSS, ZEPBOUND )  top
  • ( LOSS, ZEPBOUND, DRUG )  top
  • ( LOSS, ZEPBOUND, DRUG, FDA )  top
  • ( LOSS, ZEPBOUND, DRUG, WEGOVY )  top
  • ( LOSS, ZEPBOUND, DRUG, TAG )  top
  • ( LOSS, ZEPBOUND, DRUG, DIABETES )  top
  • ( LOSS, ZEPBOUND, MOUNJARO )  top
  • ( LOSS, ZEPBOUND, FDA )  top
  • ( LOSS, ZEPBOUND, FDA, MOUNJARO )  top
  • ( LOSS, ZEPBOUND, FDA, WEGOVY )  top
  • ( LOSS, ZEPBOUND, FDA, PEPTIDE )  top
  • ( LOSS, ZEPBOUND, FDA, INSULINOTROPIC )  top
  • ( LOSS, ZEPBOUND, FDA, HORMONE )  top
  • ( LOSS, ZEPBOUND, WEGOVY )  top
  • ( LOSS, ZEPBOUND, TAG )  top
  • ( LOSS, ZEPBOUND, PEPTIDE )  top
  • ( LOSS, ZEPBOUND, INSULINOTROPIC )  top
  • ( LOSS, WEGOVY )  top
  • ( LOSS, MOUNJARO )  top
  • ( LOSS, FDA )  top
  • ( LOSS, FDA, MOUNJARO )  top
  • ( LOSS, FDA, WEGOVY )  top
  • ( LOSS, FDA, PEPTIDE )  top
  • ( LOSS, FDA, INSULINOTROPIC )  top
  • ( LOSS, FDA, HORMONE )  top
  • ( LOSS, WEIGHT-RELATED )  top
  • ( LOSS, TAG )  top
  • ( LOSS, STOP )  top
  • References